That breakthrough led to SHIELD, the first FDA-approved blood test for colon cancer, cleared in 2024. The test is ...
One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...
Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.
Meagan Meadows, a 24-year-old teacher, was diagnosed with stage 3 colon cancer. But almost brushed off her sole symptom: blood in her stool.
The accuracy of non-invasive blood and stool-based tests for colorectal cancer is improving, but experts say it’s too soon to drop colonoscopies altogether.
The concept of a cure in oncology, particularly for stage II and III colon cancer (CC), has historically suffered from ...
BOSTON, June 1, 2025 – Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall survival post-treatment compared to those on a ...
The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient DNA mismatch repair (dMMR) colon cancer significantly improved survival in ...
She discovered blood in her stool, and quickly received tests, scans and a biopsy, which revealed the cancer was spreading to her lymph nodes She admits that when she saw the bloody stool, she could ...